Genprex, Inc (GNPX) Stock Price

2.84 ▼ -0.40 (-12.35%)
Open: 3.17 Vol: 405.98K Day's range: 2.51 - 3.17 Dec 12, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
GNPX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.81▲ 2.81▲ 2.76▲ 3.21▼ 3.32▼
MA10 2.78▲ 2.79▲ 2.93▼ 3.12▼ 3.67▼
MA20 2.85▼ 3.03▼ 3.11▼ 3.22▼ 1.94▲
MA50 3.14▼ 3.22▼ 3.18▼ 3.71▼ 1.01▲
MA100 3.24▼ 3.13▼ 3.18▼ 1.96▲ 1.66▲
MA200 3.17▼ 3.39▼ 4.22▼ 1.13▲ 23.46▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.025▲ -0.012▼ -0.045▼ 0.003▲ 0.080▲
RSI 42.817▼ 39.067▼ 38.910▼ 42.376▼ 53.528▲
STOCH 84.539▲ 45.996     22.676     59.374     25.790    
WILL %R -21.622▲ -60.544     -62.338     -71.795     -79.084▼
CCI 115.964▲ -26.840     -53.130     -67.257     6.654    
Latest Filters Detected On GNPX
MA $GNPX Price Crossed Below MA(13) Set Alert
▼ GAP $GNPX Open Gap Down %2 Set Alert
Genprex, Inc News
Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules
Tuesday, October 28, 2025 08:19 AM
$3.4 million upfront with up to an additional $6.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants AUSTIN, Texas, Oct. 28, 2025 /PRNewswire/ -- Genprex, ...
Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules
Thursday, October 23, 2025 05:12 AM
$2.7 million upfront with up to an additional $5.4 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants AUSTIN, Texas, Oct. 23, 2025 /PRNewswire/ -- Genprex, ...
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting
Wednesday, April 30, 2025 03:49 PM
Both REQORSA Alone and in Combination with LUMAKRAS® Demonstrated Robust Anti-Tumor Effects in Ras Inhibitor Resistant Non-Small Cell Lung Cancer AUSTIN, Texas, April 30, 2025 /PRNewswire/ -- Genprex, ...
GNPX historical stock data
date open high low close volume
12/12/25 3.17 3.17 2.51 2.84 405,977
11/12/25 3.32 3.34 3.22 3.24 104,195
10/12/25 3.39 3.39 3.24 3.33 109,636
09/12/25 3.39 3.4153 3.15 3.24 176,857
08/12/25 3.46 3.4931 3.26 3.39 220,601
05/12/25 3.49 3.54 3.22 3.36 300,800
04/12/25 3.09 3.68 3.0835 3.35 1,862,464
03/12/25 2.79 2.99 2.61 2.83 619,077
02/12/25 2.85 2.86 2.70 2.74 119,555
01/12/25 2.96 2.96 2.80 2.85 81,620
Quote Details
52wk Low:0.14
52wk High:12.97
Vol:405.98K
Avg Vol(3m):387.8M
1Y Chng:+234.04%
1M Chng:-50.78%
Add to Watch List
More Information
Index US Composite
Market Cap. 6.76M